World Journal of Vaccines

Volume 5, Issue 1 (February 2015)

ISSN Print: 2160-5815   ISSN Online: 2160-5823

Google-based Impact Factor: 0.86  Citations  

Effect of 7 and 13-Valent Pneumococcal Conjugate Vaccines Different Number of Doses for Pneumonia Control in 2008 and 2010 Birth Cohort Children

HTML  XML Download Download as PDF (Size: 2548KB)  PP. 37-42  
DOI: 10.4236/wjv.2015.51005    6,093 Downloads   7,043 Views  Citations

ABSTRACT

The 7-valent pneumococcal conjugate vaccine (PCV) was introduced in Uruguay in March 2008. In April 2010, it was replaced by PCV13. Surveillance of both vaccines was performed on hospitalized children with consolidated pneumonia. The effect of different number of vaccine doses was evaluated in 2008 and 2010 birth cohorts vaccinated with PCV7 and PCV13 respectively. The study aims to estimate the effects of PCV7 and PCV13 different number of doses on consolidated pneumonia, through the study of hospitalized children from 2008 and 2010 birth cohorts. Vaccination records of every child were available providing precise vaccination data; therefore a new approach was used to estimate PCVs effect. Incidence rate was calculated for each year of the study and for the different number of vaccine doses used each year. Exposure was calculated as person per year and rate ratio values determined the decrease of consolidated pneumonias. This decrease in percentage was estimated as the difference between the incidence with no vaccine and the incidence of every one of the doses. Incidence rate ratio revealed significant values for the three vaccine doses of PCVs for both cohorts. Upon comparing incidences, significant reduction percentages of consolidated pneumonia admissions were found. The reduction percentage of consolidated pneumonia for fully vaccinated (3 doses) patients was 69.3% and 84.6 % for PCV7 and PCV13, respectively. These results confirm that PCV7 and PCV13 are highly effective for reducing pediatric hospitalizations due to consolidated pneumonia, as reported by other national publications and demonstrated by international researchers.

Share and Cite:

Hortal, M. , Meny, M. , Estevan, M. , Arrieta, F. and Laurani, H. (2015) Effect of 7 and 13-Valent Pneumococcal Conjugate Vaccines Different Number of Doses for Pneumonia Control in 2008 and 2010 Birth Cohort Children. World Journal of Vaccines, 5, 37-42. doi: 10.4236/wjv.2015.51005.

Cited by

[1] СОВЕРШЕНСТВОВАНИЕ СИСТЕМЫ ЭПИДЕМИОЛОГИЧЕСКОГО НАДЗОРА ЗА ВНЕБОЛЬНИЧНЫМИ ПНЕВМОНИЯМИ НА ТЕРРИТОРИИ КРУПНОЙ ПРОМЫШЛЕННОЙ ОБЛАСТИ В УСЛОВИЯХ ВАКЦИНОПРОФИЛАКТИКИ
Thesis, 2019
[2] Совершенствование системы эпидемиологического надзора за внебольничными пневмониями на территории крупной промышленной области в …
2019
[3] RISK FACTORS IN CHILDREN PRESENTING WITH ACUTE RESPIRATORY INFECTIONS-AN EXPERIENCE AT POF HOSPITAL, WAH CANTT.
2017
[4] Impact and effectiveness of 10 and 13-valent pneumococcal conjugate vaccines on hospitalization and mortality in children aged less than 5 years in Latin …
2016
[5] FluMist", Prevnar 13") resulted in highly successful product launches. I have spearheaded the
2016
[6] Impact and Effectiveness of 10 and 13-Valent Pneumococcal Conjugate Vaccines on Hospitalization and Mortality in Children Aged Less than 5 Years in Latin …
PLOS ONE, 2016
[7] Camacho LAB, Coutinho ESF, Martinez-Silveira MS, Carvalho AF, Ruiz-Matus C, et al.(2016) Impact and Effectiveness of 10 and 13-Valent Pneumococcal …
2016

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.